Regions Financial Corp Bristol Myers Squibb CO Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Regions Financial Corp holds 169,883 shares of BMY stock, worth $10 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

169,883

Previous 181,177 6.23%

Holding current value

$10 Million

Previous $7.52 Million 16.84%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $447,920 - $584,464	-11,294 Reduced 6.23%	169,883 $8.79 Million
Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $2.04 Million - $2.68 Million	-50,630 Reduced 21.84%	181,177 $7.52 Million
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $953,602 - $1.08 Million	-19,875 Reduced 7.9%	231,807 $12.6 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $1.16 Million - $1.39 Million	-23,977 Reduced 8.7%	251,682 $12.9 Million
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $1.74 Million - $1.95 Million	-30,078 Reduced 9.84%	275,659 $16 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $4.05 Million - $4.5 Million	-63,560 Reduced 17.21%	305,737 $19.6 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $27.2 Million - $30.8 Million	-413,473 Reduced 52.82%	369,297 $25.6 Million
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $1.36 Million - $1.61 Million	-19,907 Reduced 2.48%	782,770 $56.3 Million
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $633 - $374,671	-4,876 Reduced 0.6%	802,677 $57.1 Million
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $2.75 Million - $3.03 Million	-37,870 Reduced 4.48%	807,553 $62.2 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $11,312 - $13,564	184 Added 0.02%	845,423 $61.7 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $542,467 - $632,389	-10,115 Reduced 1.18%	845,239 $52.7 Million
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $676,135 - $792,005	-11,427 Reduced 1.32%	855,354 $50.6 Million
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $275,809 - $300,356	-4,455 Reduced 0.51%	866,781 $57.9 Million
Q1 2021 Jun 02, 2021	SELL	$59.34 - $66.74 $415,854 - $467,713	-7,008 Reduced 0.8%	871,236 $55 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $322,535 - $365,491	5,586 Added 0.64%	878,244 $54.5 Million
Q3 2020 Oct 15, 2020	BUY	$57.43 - $63.64 $242,412 - $268,624	4,221 Added 0.49%	872,658 $52.6 Million
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $1.06 Million - $1.23 Million	19,249 Added 2.27%	868,437 $51.1 Million
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $5.96 Million - $8.67 Million	128,520 Added 17.83%	849,188 $47.3 Million
Q4 2019 Feb 03, 2020	SELL	$49.21 - $64.19 $4.01 Million - $5.22 Million	-81,387 Reduced 10.15%	720,668 $46.3 Million
Q3 2019 Oct 24, 2019	BUY	$42.77 - $50.71 $488,604 - $579,311	11,424 Added 1.44%	802,055 $40.7 Million
Q2 2019 Jul 19, 2019	BUY	$44.62 - $49.34 $1.51 Million - $1.67 Million	33,845 Added 4.47%	790,631 $35.9 Million
Q1 2019 Apr 19, 2019	BUY	$45.12 - $53.8 $1.59 Million - $1.9 Million	35,254 Added 4.89%	756,786 $36.1 Million
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $1.17 Million - $1.51 Million	-23,933 Reduced 3.21%	721,532 $37.5 Million
Q3 2018 Oct 22, 2018	SELL	$55.19 - $62.25 $2.18 Million - $2.46 Million	-39,479 Reduced 5.03%	745,465 $46.3 Million
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $4.03 Million - $5.02 Million	-79,693 Reduced 9.22%	784,944 $43.4 Million
Q1 2018 Apr 18, 2018	BUY	$59.92 - $68.98 $1.26 Million - $1.45 Million	20,954 Added 2.48%	864,637 $54.7 Million
Q4 2017 Jan 18, 2018	BUY	$59.94 - $65.35 $3.56 Million - $3.88 Million	59,418 Added 7.58%	843,683 $51.7 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $43.3 Million - $50 Million	784,265	784,265 $50 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Bristol Myers Squibb CO Transaction History